Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TJ3M
|
|||
| Former ID |
DIB002814
|
|||
| Drug Name |
NSC-281612
|
|||
| Synonyms |
Benzaldehyde dimethane sulfonate; Dimethane sulfonate; Methylene dimethane sulfonate; DMS-612
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
National Cancer Institute
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H21NO7S2
|
|||
| Canonical SMILES |
CC1=C(C=CC(=C1)N(CCOS(=O)(=O)C)CCOS(=O)(=O)C)C=O
|
|||
| InChI |
1S/C14H21NO7S2/c1-12-10-14(5-4-13(12)11-16)15(6-8-21-23(2,17)18)7-9-22-24(3,19)20/h4-5,10-11H,6-9H2,1-3H3
|
|||
| InChIKey |
CQVKMVQRSNNAGO-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 56967-08-9
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00923520) A Phase 1, Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous Dimethane Sulfonate (DMS612) in Advanced Malignancies. U.S. NationalInstitutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.